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Retinoids are important modulators for cell growth and differentiation of normal skin. In plasma, retinol is
transported coupled to plasma retinol-binding protein. In this study, we investigated gene and protein expression
of RPE65, a putative receptor for plasma retinol-binding protein in human epidermal keratinocytes. We performed
real-time PCR analysis to evaluate expression of RPE65 mRNA in proliferating and differentiating keratinocytes.
Immunoblotting with anti-RPE65 antibody shows distinct reactivity to a 61-kDa protein. Indirect immunoﬂuores-
cence on normal human epidermis reveals cell surface labeling of keratinocytes. Laser scan microscopy exhibits
colocalization of plasma retinol-binding protein and RPE65 on cultured keratinocytes. Internalization experiments
with [3H]retinoic acid–retinol-binding protein complex in the presence and absence of excess of retinol-binding
protein indicates receptor-dependent uptake of retinoids. We further show isolation of RPE65 protein by afﬁnity
chromatography from lysates of keratinocytes using a retinol-binding protein-matrix gel column. In summary, we
demonstrate mRNA and protein expression of RPE65 in epidermal keratinocytes. Colocalization of plasma retinol-
binding protein with RPE65 and afﬁnity binding suggest a direct interaction of RPE65 with plasma retinol-binding
protein in cultured human keratinocytes that might be involved in retinoid uptake of keratinocytes.
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Vitamin A and its derivatives, the retinoids, play an
important role in a wide spectrum of biologic processes
such as vision, cell growth, or development (Napoli, 1996,
1999). By regulating gene expression retinoids influence
target cells involving specific extra- and intracellular
proteins (Blomhoff et al, 1990; Roos et al, 1998). Cellular
retinol-binding proteins (RBP) act as carriers for retinol and
affect trafficking, metabolism and storage of retinoids in the
cytoplasm (Li and Norris, 1996). In the nucleus, retinoic acid
receptors and 9-cis-retinoic acid receptors act as ligand-
dependent transcription factors mediating gene regulation
(Chambon, 1996) and are known to mediate retinoid activity
within the cell (Giguere et al, 1987; Petkovich et al, 1987).
Retinoids alter the expression of growth factors, transcrip-
tion factors, and oncogenes, encoding a number of different
regulatory proteins thus modulating epidermal growth and
differentiation either directly or indirectly. In the epidermis,
retinoic acid suppresses differentiation of basal keratino-
cytes and promotes cell proliferation (Fisher and Voorhees,
1996) influencing normal squamous differentiation of the
skin (Roos et al, 1998).
In serum, plasma RBP, a 21-kDa protein of the lipocalin
family (Newcomer and Ong, 2000), acts in the transport and
delivery of retinol from the liver, where dietary retinoids are
stored and secreted as retinol bound to plasma RBP
(Blomhoff et al, 1990). Retinol–RBP in plasma is also
reported to form a complex of approximately 55 kDa with
transthyretin to prevent elimination by glomerular filtration in
the kidney (Wei et al, 1995). Whereas the mode of retinoid
action via nuclear retinoid acid receptors and retinoid X
receptors (Petkovich et al, 1987; Chambon, 1996; Fisher
and Voorhees, 1996) regulating gene expression appears to
be undisputed, the mechanism of cellular retinol uptake has
been reported controversially (Noy, 2000). Some studies
have supported the hypothesis of a nonspecific receptor-
independent way like diffusion across target cell mem-
branes (Noy and Xu, 1990; Van Bennekum et al, 1993).
Other investigators have suggested the theory of a specific
plasma RBP receptor-mediated uptake involving a receptor
that recognizes the protein part of the plasma RBP–retinol
complex (Rask and Peterson, 1976; Sivaprasadarao and
Findlay, 1988; Bavik et al, 1991). A possible receptor for
plasma RBP has been studied in tissues like intestine,
testis, liver, and placenta (Rask and Peterson, 1976;
Shingleton et al, 1989; Senoo et al, 1993; Sivaprasadarao
et al, 1994). The mode of uptake of retinol into human
keratinocytes is also a matter of controversial discussion
(Vahlquist and Torma, 1992; Creek et al, 1993). Some
authors show data supporting the hypothesis of receptor
independent delivery of retinol to human keratinocytes
(Hodam et al, 1991; Hodam and Creek, 1998), and, in
Abbreviations: CT, threshold cycle; NP-40, Nonidet P-40; PAGE,
polyacrylamide gel electrophoresis; PBS, phosphate-buffered
saline; RBP, retinol-binding protein; SDS, sodium dodecyl sulfate.
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contrast, studies propose that a regulated retinol transfer
into human keratinocytes implies involvement of a receptor
protein to which the RBP of the RBP–retinol complex is
bound (Bavik et al, 1995; Smeland et al, 1995). A putative
receptor for plasma RBP has been assigned to a 61-kDa
protein (named RPE65) which was originally identified in
retinal pigment epithelium cells (Bavik et al, 1992; Hamel
et al, 1993; Bavik et al, 1995; Nicoletti et al, 1995). This
protein is highly conserved across various species and is
predominantly expressed in the retinal pigment epithelium
(Bavik et al, 1993; Nicoletti et al, 1995). The physiologic role
of RPE65 is under debate. It has been reported to be
membrane associated but not to be an integral membrane
protein lacking hydrophobic transmembrane domains and
signaling peptides (Bavik et al, 1992; Hamel et al, 1993;
Nicoletti et al, 1995; Flower, 2000). The abundant expres-
sion in retinal pigment epithelium indicates an important role
for RPE65 in retinoid processing and transport in the eye
suggesting to be involved in human retinal degenerations
(Nicoletti et al, 1995). RPE65 gene mutations have been
shown to cause inherited retinal dystrophies (Gu et al, 1997;
Morimura et al, 1998; Redmond et al, 1998). In this study we
demonstrate RPE65 gene and protein expression in human
keratinocytes and find evidence for RPE65 to play a role as
receptor molecule for RBP in retinoid uptake.
Results
Expression of RPE65 mRNA in human epidermal
keratinocytes To demonstrate gene expression of RPE65
originally identified and sequenced in retinal pigment
epithelial cells (Nicoletti et al, 1995) in cultured human
keratinocytes, we performed real-time PCR using specific
primers and probes for human RPE65 as given under
Materials and Methods. As a control, mRNA of ARPE-19, a
cell line expressing RPE65, was used for real-time PCR.
TaqMan real-time PCR assay based on measurement of
threshold cycle (CT) values was employed. CT value is
associated with an increasing detection signal as a result of
the exponential growth of the PCR product. CT values of
RPE65 and b-actin were measured from ARPE-19 cells and
from proliferating and differentiating—induced by conflu-
ence as well as by 1 mM Ca2þ exposure for 24 h—
keratinocytes. CT and DCT of ARPE-19 cells (mean values
from three different runs) were 34.92  0.70 and
18.47  0.24, respectively. To evaluate a possible difference
in mRNA expression of keratinocytes at the various
conditions we applied a comparative CT method. Expres-
sion of RPE65 mRNA in the differentiating keratinocytes—
each—was compared to the proliferating cells. The relative
quantity of RPE65 mRNA in proliferating keratinocytes is
given 1 (calibrator). The relative quantity (2DDCT) of RPE65
mRNA in differentiating keratinocytes induced by conflu-
ence is 0.93, whereas high-calcium-exposed keratinocytes
give a value of 0.74. The differences in the relative amount
of RPE65 mRNA expression between confluence-induced
differentiating and proliferating keratinocytes as well as
between calcium-induced differentiating keratinocytes and
proliferating keratinocytes were not statistically significant;
p values were 0.56 and 0.11, respectively. The mean values
with standard deviations of five different donors are shown
in Table I.
Protein expression of RPE65 in human epidermal
keratinocytes We have raised a peptide-specific rabbit
antibody according to previous publications that assigned
the peptide NFITKINPETLETIK of the RPE65 protein as
antigenic and respective antibodies as useful reagents to
identify RPE65 (Redmond and Hamel, 2000; Ma et al, 2001).
To obtain an affinity-purified antibody to RPE65 the rabbit
serum was passed through a column of the respective
peptide coupled to a polymer resin. We tested protein
expression of RPE65 using the affinity-purified antibody for
immunoblotting lysates of cultured human keratinocytes
and, for control, lysates of ARPE-19 cells expressing
RPE65. The affinity-purified rabbit antibody reacted with a
single band of approximately 61 kDa (Fig 1A, lane 1),
whereas the irrelevant rabbit IgG shows no specific
reactivity (Fig 1A, lane 3). Immunoblotting with peptide-
specific RPE65 antibodies in the presence of excess free
synthetic peptide NFITKINPETLETIK revealed no reactivity
(Fig 1A, lane 2). The peptide-specific RPE65 antibody
revealed a single band within protein extracts of retinal
pigment epithelial cells (Fig 1B, lane 1). This reactivity has
also been competed by the presence of the respective
synthetic peptide (Fig 1B, lane 2).
Indirect immunoﬂuorescence reveals RPE65 at the cell
periphery of epidermal keratinocytes Indirect immuno-
Table I. Comparison of RPE65 mRNA expression among proliferating and differentiating keratinocytes by comparative CT method
Keratinocytes
RPE65
(mean CT
a  SD)
b-Actin
(mean CT
a  SD) Mean DCTb  SD DDCTc  SD
RPE65 mRNA
expression relative
to proliferating
keratinocytes (2DDCT)
Proliferating 34.54  0.97 17.96  1.43 16.58  1.22 0.0  1.22 1
Differentiating
Confluence induced 35.54  2.51 18.85  1.68 16.69  1.28 0.11  1.28 0.93 (0.38–2.25)
Induced by high calcium 35.87  2.50 18.93  1.64 17.02  1.19 0.44  1.19 0.74 (0.32–1.68)
aCT, threshold cycle.
bDCT¼CTRPE65CT b-actin.
cDDCT¼mean DCT (mRNA of confluence induced/calcium induced differentiating keratinocytes)mean DCT calibrator (proliferating keratinocytes).
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fluorescence on normal human epidermis performed with
affinity-purified anti-RPE65 antibody reveals distinct mem-
brane-associated labeling suggesting RPE65 at the cell
surface of keratinocytes. The labeling is predominantly
localized to the keratinocytes of the basal and suprabasal
cell layers. Individual keratinocytes show also a dotted
appearing surface labeling pattern (Fig 2A). There appears
to be a slight decrease in labeling intensity from the basal to
the upper cell layers, leaving the horny cell layers negative
(Fig 2A).
RPE65 protein and plasma RBP colocalize in human
keratinocytes RPE65 expression was also demonstrated
on paraformaldehyde-lysine-periodate–fixed, permeabilized
cultured human keratinocytes by indirect immunofluores-
cence. Double labeling was performed to evaluate possible
colocalization of plasma RBP and RPE65. We used the
affinity-purified rabbit anti-RPE65 antibody and a sheep
anti-RBP antibody with respective detector reagents. RBP
appears as dotted fluorescence pattern on the cell surface
and as vesicular staining in the subcellular cell periphery
and throughout the cytoplasm (Fig 3A). RPE65 gives a very
similar fluorescence signal (Fig 3B). To a large degree, RBP
is found to be colocalized to RPE65, and colocalization
appears to be most prominent in individual vesicles at the
cell periphery indicating vesicular uptake of plasma RBP
into keratinocytes (Fig 3C). Controls using only second step
antibodies showed no specific reactivity on cells (not
shown).
Uptake experiments suggest RBP-dependent retinoid
uptake by human keratinocytes To evaluate uptake of
[3H]retinoic acid, proliferating keratinocytes were incubated
with culture medium containing [3H]retinoic acid coupled to
RBP, as discussed under Materials and Methods, at 371C and
41C for different time spans. When the cells were incubated
for 1, 3, 5, and 10 min at 371C with the incubation mixture,
measured cell associated radioactivity was between
173  40 and 247  65 cpm per 5  102 cells (per mL).
Mean values and SD represent triplicate determination of
measurement. Cell-associated radioactivity is significantly
lower when incubation steps were performed at 41C
(p¼0.004) (Fig 4). When an excess of uncoupled RBP
Figure 2
RPE65 expression in normal human epidermis. Indirect immuno-
fluorescence performed on normal skin with peptide-specific anti-
RPE65 antibody reveals a distinct cell surface labeling (A). Individual
keratinocytes predominantly from the basal and suprabasal cell layer
exhibit a membrane associated dotted fluorescence pattern (A). The
upper granular cell layer and the horny cell layer shows no specific
labeling (A). Immunofluorescence labeling with irrelevant rabbit IgG was
negative (B). Bar, 20 mm.
Figure 3
Plasma RBP and RPE65 colocalize in cultured human keratinocytes. Paraformaldehyde-lysine-periodate–fixed, permeabilized cultured
keratinocytes were used for indirect immunofluorescence experiments and investigated by laser scanning microscopy. Plasma RBP detected by a
sheep anti-RBP antibody and Alexa 488-conjugated donkey anti-sheep second step is found in a cell surface pattern and also in small dots at the
subcellular cell periphery indicating a vesicular staining pattern (green, A). RPE65 detected by the peptide-specific anti-RPE65 antibody and TRITC-
conjugated donkey anti-rabbit second step shows a similar fluorescence labeling (red, B). Using the multitrack scan to a great part colocalization of
both, RBP and RPE65 could be demonstrated as shown by the orange color in C. Bar, 20 mm.
Figure 1
Biochemical detection of RPE65 protein in human epidermal
keratinocytes. Lysates of cultured human keratinocytes (A)
and ARPE-19 cells (B) were run on the same gel for SDS-PAGE and
transferred to nitrocellulose. Strips of both lysates were cut out,
and immunoblotting was performed using the peptide-specific anti-
RPE65 antibody. The antibody reacted specifically with an antigen of
approximately 61 kDa (arrow) within both the keratinocyte extract
(A, lane 1) and the retinal pigment epithelial cell extract (B, lane 1). The
specificity of the antibody was also documented by competitive
inhibition of antibody binding with an excess of corresponding
synthetic peptide (A and B, lane 2). Immunoblotting with irrelevant
rabbit IgG showed no specific reactivity (A and B, lane 3).
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was added to the incubation mixture at 371C, again, a
significant reduction (p¼ 0.003) of [3H]retinoic acid uptake
was found (Fig 4) indicating competitive inhibition of
[3H]retinoic acid–RBP by pure RBP. These findings strongly
suggest receptor associated uptake of RBP-retinoids in
human keratinocytes.
Human plasma RBP binds to RPE65 Human plasma RBP
(Biotrend) covalently bound to a matrix gel was used as
affinity column to specifically bind proteins from NP-40
extracts. To determine possible interactions of plasma RBP
as ligand with a putative receptor protein from human
keratinocytes, we incubated the RBP-coupled matrix gel
with NP-40-extracted proteins of keratinocytes. To separate
bound proteins from the RBP-matrix gel, the mixture was
boiled in 10% SDS sample buffer and the supernatant was
loaded onto a 12% slab gel. After PAGE and electrophoretic
transfer to nitrocellulose, strips were cut out and incubated
with the affinity-purified anti-RPE65 antibody. The antibody
recognizes a distinct, single band of approximately 61 kDa
(Fig 5, lane 1) indicating RPE65 affinity isolation by the RBP
column. Immunoblotting peptide-specific antibody in the
presence of excess synthetic peptide (Fig 5, lane 2) as well
as irrelevant rabbit IgG (Fig 5, lane 3) gave no specific
reactivity. When RBP-matrix gel alone was exposed to SDS
sample buffer, run for SDS-PAGE, and transferred to
nitrocellulose, immunoblotting with anti-peptide antibody
and irrelevant rabbit IgG showed no reactivity (not shown).
Discussion
In this study we give molecular biologic, immunomorpho-
logic, and biochemical evidence for the presence of RPE65
in cultured human keratinocytes. We used specific primers
and probes to show RPE65 gene expression in cultured
human keratinocytes by real-time PCR. Originally, RPE65
was identified in retinal pigment epithelium and described to
be there expressed abundantly with a calculated molecular
mass of 61 kDa (Bavik et al, 1992; Nicoletti et al, 1995). As
control, ARPE-19, a retinal pigment epithelium cell line that
expresses RPE65, was applied. Nevertheless, previous obser-
vations show a reduced RPE65 mRNA and protein expres-
sion in retinal pigment epithelial cells in cell culture (Nicoletti
et al, 1995), where decreased mRNA suggested regulation
of RPE65 protein synthesis occurring at the transcriptional
level and reduced protein might reflect decreased promoter
activity owing to loss of tissue-specific regulatory factors,
inhibition of translation, or degradation of mRNA (Nicoletti
et al, 1995; Boulanger and Redmond, 2002).
Recent molecular and biochemical investigations have
shown that antibodies raised to amino acids 150 to 164
(NFITKINPETLETIK) of RPE65 protein represent specific
anti-RPE65 antibodies (Redmond et al, 1998; Ma et al,
2001). Based on these observations, we generated a
polyclonal, affinity-purified peptide-specific antibody. This
antibody recognized a single antigen of approximately 61
kDa in lysates of keratinocytes and of ARPE-19 cells. In the
presence of an excess of free synthetic peptide (NFITKIN-
PETLETIK), the binding of the antibody could be competed
supporting antibody specificity. Indirect immunofluores-
cence on normal human skin showed distinct surface
labeling of the individual keratinocytes predominantly in
the basal and suprabasal cell layers. When we performed
double immunofluorescence on proliferating cultured kera-
tinocytes, we found to a great extent plasma RBP to be
colocalized with the RPE65 protein, suggesting an interac-
tion of RBP with RPE65. The colocalization appeared more
concentrated on the cell periphery and largely in a vesicular
peripheral pattern. These observations are suggestive of a
possible receptor-mediated vesicular uptake of plasma
Figure 4
Retinoid uptake in keratinocytes is RBP-dependent. Proliferating
cultured human keratinocytes were incubated with culture medium
containing [3H]retinoic acid–RBP complex at 371C for 1, 3, 5, and 10
min. Cell-associated radioactivity was evaluated by liquid scintillation
from cells harvested in PBS (300 mL PBS for 1.5  105 cells) expressed
in cpm per 5  102 cells. The values result from three different mea-
surements. There is a slight but statistically not significant increase at
10 min. When incubation steps were performed at 41C cell-associated
radioactivity is drastically reduced compared to incubation at 371C
(p¼ 0.004). Nearly the same effect was reached when incubation was
performed in the presence of excess unbound RBP competitively
inhibiting the [3H]retinoic acid–RBP complex (p¼0.003) compared to
incubation at 371C.
Figure5
Human plasma RBP coupled to a resin matrix binds to RPE65 of
keratinocyte lysates. Ethanol-acetone–precipitated proteins of NP-40
lysates of cultured keratinocytes were dissolved in PBS and exposed to
the RBP column. Bound proteins were eluted by SDS-sample buffer
and loaded onto a 12% gel for PAGE and transferred to nitrocellulose.
Immunoblotting with the peptide-specific anti-RPE65 antibody showed
a single specific reacting band of approximately 61 kDa (lane 1, arrow).
Competitive inhibition of antibody binding with excess of free peptide
(lane 2) and irrelevant rabbit IgG showed no specific reaction (lane 3).
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RBP and go in line with previous studies that have shown
internalization of plasma RBP–retinol via receptor-mediated
endocytosis in hepatocytes (Malaba et al, 1995) and,
similarly, in liver stellate cells (Senoo et al, 1993). Therefore,
one can imagine that the uptake of retinol into cells entails
interaction of the carrier protein plasma RBP with the
respective receptor molecule (Senoo et al, 1993; Sundaram
et al, 1998). Nevertheless, we find more RBP labeling
intracellularly compared to RPE65 that is predominantly
seen at the cell surface. This could be explained by
vesicular uptake of bound RBP that is enriched in the cell,
whereas RPE65 as a possible receptor could be relocated
to the cell surface. A very recent study also shows retinol-
binding affinity for RPE65 by itself in bovine pigment
epithelium membranes (Jahng et al, 2003), and studies with
cultured keratinocytes have also shown receptor-indepen-
dent uptake of retinoids (Hodam et al, 1991; Hodam and
Creek, 1998). Therefore, based on previous studies that
show binding affinity of RBP to its ligands like retinol or
retinoic acid we performed complexation of [3H]retinoic acid
with RBP (Horwitz and Heller, 1973; Zanotti et al, 1994)
and used it to test uptake of a retinol analog in a form
complexed with RBP in cultured human keratinocytes. We
performed internalization experiments at 371C from 1 up to
10 min, a time span where according to standard protocols
vesicular uptake is effective. This uptake could be inhibited
competitively by an excess of RBP alone and is also
significantly reduced at 41C, when vesicular uptake is
arrested. These data demonstrate that receptor-mediated
vesicular uptake of retinoid–RBP in complexed form could
be involved in the retinoid pathway of epidermal keratino-
cytes.
To evaluate a possible direct interaction of RBP and the
RPE65 protein, we obtained human RBP coupled to a resin
matrix and incubated it with NP-40 protein extracts of
keratinocytes. NP-40 allows the protein to be extracted in
the biologically active form thus enabling RPE65 to bind
RBP. The protein eluted from the RBP column was
recognized by the anti-RPE65 antibody. This result gives
high evidence for direct binding affinity of RBP to RPE65
acting as a putative receptor molecule. Nevertheless,
RPE65 has been reported to be membrane associated
but not to be an integral membrane protein because it is
lacking hydrophobic transmembrane domains and a signal
peptide (Bavik et al, 1993; Hamel et al, 1993; Nicoletti et al,
1995). The knowledge on the structure of the protein is
limited, and the possible receptor function of RPE65
for plasma RBP has been discussed and is still unclear
(Bavik et al, 1993; Hamel et al, 1993; Nicoletti et al, 1995;
Redmond et al, 1998; Flower, 2000). As abundantly
expressed in retinal pigment epithelial cells, RPE65 was
shown to be involved in the all-trans- to 11-cis-isomeriza-
tion reaction that regenerates the 11-cis-retinal chromo-
phore of rhodopsin in the visual cycle of the retina
(Redmond et al, 1998). Recent studies have shown high
sequence homology between bovine RPE65 and mouse a-
carotene 15,150-dioxygenases (Redmond et al, 2001; von
Lintig and Wyss, 2001), an essential enzyme in metabolism
of carotene to vitamin A. The functional role of RPE65 in
the enzymatic processing is not yet clear whether this
homology is due to a conserved carotenoid/retinoid
binding motif or related biochemical function (von Lintig
and Wyss, 2001). Studies consider RPE65, primarily also
described as p63, a likely receptor molecule (Bavik et al,
1991, 1993) for plasma RBP and therefore of importance
for retinol uptake.
Differentiation of epidermal keratinocytes could be
influenced by a monoclonal anti-p63 (means RPE65) anti-
body when RBP–retinol complex was administered in cell
culture (Bavik et al, 1995) demonstrating that retinol might
block differentiation of cultured human keratinocytes when
administered as a complex with RBP to the culture medium.
When we compared mRNA from proliferating to differentiat-
ing keratinocytes, we found a slight, but not statistically
significant, decrease of RPE65 mRNA expression. Retinoids
are important for proliferation of keratinocytes in cell culture.
When epidermal keratinocytes are cultured in the absence
of vitamin A, the cells display features of terminal
differentiation (Fuchs and Green, 1981) including stratifica-
tion, cell adhesiveness, and expression of keratin 1 and 10
(Fuchs, 1990). Colocalization of RPE65 and RBP, which
might also be produced by the keratinocytes (Torma et al,
1994), and in vitro binding of RBP to RPE65 suggest direct
interaction of these molecules and a likely receptor function
of RPE65 in epidermal keratinocytes.
Many signal-transducing receptors are plasma mem-
brane proteins that bind specific extracellular molecules
such as growth factors, hormones, or neurotransmitters
transmitting signals eliciting specific responses. Posttran-
slationally modified proteins with hydrophobic anchors that
include fatty acids, isoprenoids and glycosyl-phosphatidyl
inositol by which membrane-associated proteins might be
bound to the plasma membrane have been identified
(Magee et al, 1989). For example, glycosyl-phosphatidyl
inositol acts as membrane anchor for the Fc receptor
molecule FcgRIIIB, which may exert receptor function
(Ravetch and Perussia, 1989). FcgRIIIB has no triggering
capability by itself but appears to transduce signals with
additive receptor proteins like FcgRIIA (Heijnen and van de
Winkel, 1997). It could well be that RPE65 exerts peculiar
receptor function eliciting ligand binding and cell signaling
in an appropriate fashion influenced by additional plasma-
lemmal proteins or cell-specific regulation factors influen-
cing transcription and protein function. Studies supporting
that possibility demonstrated RPE65 in some transformed
kidney cells and not in primary kidney cultures indicating
that RPE65 gene transcription might for example be
dependent on different neoplastic transformation (Ma et al,
1999). More recently, human RPE65 expression using the
baculovirus system revealed the protein in two forms, one of
which is a cytosolic form, partly found in microsomes and a
membrane associated form exhibiting significant posttran-
slational modifications (Ma et al, 2001).
Summarizing our data, we demonstrate RPE65 gene and
protein expression in cultured human keratinocytes and find
evidence for receptor-mediated endocytosis involved in
retinoid–RBP uptake. Double immunofluorescence on ker-
atinocytes shows colocalization of RBP and RPE65 and
affinity binding of RPE65 to plasma RPB suggests interac-
tion of these two molecules in cultured human keratinocytes
supporting the hypothesis of a possible receptor function of
RPE65 protein.
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Materials and Methods
Cell culture, antibodies, and reagents Normal human keratino-
cytes were isolated from skin samples of adults, obtained from
healthy volunteers after cutaneous surgery. Donors gave informed
consent. The protocol was approved by the Institutional Review
Board. Keratinocytes were grown to confluence in keratinocyte
growth medium (Clonetics, San Diego, CA) including bovine
pituitary extract as described previously (Boyce and Ham, 1983).
Briefly, epidermis was separated by incubation in 50 caseolytic
units per mL dispase (Collaborative, Bedford, MA) for 2 h at 371C.
After incubation in trypsin/ethylenediaminetetraacetic acid (Clo-
netics) for 30 min at 371C, a single-cell suspension of keratinocytes
was released by pipetting and cultured to near confluence using
keratinocyte growth medium (Clonetics). In addition, keratinocytes
were grown to confluence until spike formation resulting in
differentiation and used after 24 h. Alternatively, cells grown to
near confluence were incubated for 24 h with 1 mM Ca2þ to
induce differentiation. ARPE-19, a human retinal pigment epithe-
lium cell line expressing RPE65, was purchased from American
Type Culture Collection (ATCC, Manassas, VA) and grown in a 1:1
mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12
medium (ATCC) supplemented with 10% fetal bovine serum for
4 d. Cells were grown in 100  20-mm petri dishes using appropriate
growth medium to obtain extracts for immunoblotting, in eight-well
chamber slides (Becton Dickinson, Franklin Lakes, NJ) for
immunofluorescence experiments and in T-150 flasks (Techno
Plastic Products, Trasadingen, Switzerland) for mRNA isolation.
For colocalization by indirect immunofluorescence, a sheep
antibody against plasma RBP was purchased from Chemicon
(Temecula, CA). As second step antibodies, Alexa 488-conjugated
donkey anti-sheep IgG from Molecular Probes (Eugene, OR) and
TRITC-conjugated donkey anti-rabbit IgG from Chemicon were
used. For immunoblotting alkaline phosphatase-conjugated goat
anti-rabbit IgG (Promega, Madison, WI) was used as second
antibody. For control studies, irrelevant rabbit IgG was obtained
from Sigma Chemical Co. (St. Louis, MO). Human RBP was
purchased from Biotrend (Cologne, Germany).
Generation of afﬁnity-puriﬁed peptide-speciﬁc anti-RPE65
antibody A synthetic peptide comprising a 15-amino-acid se-
quence (amino acids 150–164), NFITKINPETLETIK, of RPE65
protein (Nicoletti et al, 1995) described earlier as antigenic target
for antibody generation (Redmond and Hamel, 2000) synthesized
on branched oligolysines as carrier was produced by piChem R &
D (Graz, Austria) and used as antigen to raise an anti-peptide rabbit
antibody (Posnett et al, 1988; Butz et al, 1994). The rabbit was
immunized by Charles River (Kisslegg, Germany) according to
standard protocols. For affinity purification of the antibody, the
peptide NFITKINPETLETIK was synthesized on a beaded poly-
styrene polyoxyethylene graft copolymer resin with a coupling
intensity of 0.17 mmol per g by piChem R & D (Butz et al, 1994). A
quantity of 330 mg of that gel matrix was loaded onto a 10-mL
disposable column (Pierce, Rockford, IL), swollen in 70% ethanol,
and conditioned with 10 mM Tris-HCl, pH 7.4. A quantity of 200 mL
of polyclonal rabbit serum diluted in 1800 mL ImmunoPure Gentle
binding buffer (ImmunoPure Gentle Ag/Ab Buffers, Pierce, Rock-
ford, IL) was incubated overnight at room temperature under gentle
shaking, washed with 20 column vol 10 mM Tris-HCl, pH 7.4,
followed by elution with 4 mL ImmunoPure Gentle elution buffer
(ImmunoPure Gentle Ag/Ab buffers, Pierce). Eluted affinity-purified
anti-RPE65 antibodies were pooled, dialyzed against phosphate-
buffered saline (PBS), pH 7.4, and concentrated (to 100 mg per 100
mL) with Centricon-30 microconcentrators (Amicon, Beverly, MA).
In addition, free peptide NFITKINPETLETIK was purchased from
piChem R & D and used for competitive inhibition of antibody
binding.
Qualitative and quantitative real-time PCR (TaqMan) analysis
Real-time PCR experiments were performed as described pre-
viously (Cauza et al, 2002). Human keratinocytes obtained from five
different donors were cultured and cell pellets of proliferating and
differentiating—induced by confluence as well as by 1 mM Ca2þ—
keratinocytes were used for RNA isolation. For control, mRNA of
ARPE-19 cells was used. Total RNA was extracted using Qiagen
RNeasy Midi kit (Qiagen, Valencia, CA) according to the manu-
facturer’s protocol (RNeasy Midi/Maxi Handbook, second edition,
November 2001, Qiagen). Approximately 600 ng of total RNA
diluted in sterile distilled water was reverse transcribed using
TaqMan reverse transcription reagents kit (Applied Biosystems,
Foster City, CA) according to the manufacturer’s instruction
(TaqMan universal master mix protocol, Applied Biosystems). The
reaction was performed in the presence of 10 mL of 10  TaqMan
reverse transcription buffer, 22 mL of 25 mM magnesium chloride
(5.5 mM), 20 mL deoxy-NTPs mixture (500 mM of each dNTP), 5 mL
of random hexamer (2.5 mM), 2 mL of RNase inhibitor (0.4 U per mL),
2.5 mL of MultiScribe reverse transcriptase (1.25 U per mL), and
38.5 mL of RNA (about 600 ng in sterile distilled water). The final
solution (100 mL) was incubated for 10 min at 251C, 30 min at 481C,
and 5 min at 951C. Five microliters of resulting cDNA solution was
used as PCR template in the presence of 12.5 mL of TaqMan
universal master mix (Applied Biosystems), 1 mL (5 pmol per mL) of
gene-specific TaqMan probe, 3.7 mL (6 pmol per mL) of gene-
specific forward and 2 mL (11 pmol per mL) of reverse primer, and
0.8 mL of sterile distilled water. Each cDNA was also amplified in
the presence of 12.5 mL TaqMan universal master mix, 1.25 mL of b-
actin (Applied Biosystems) as endogenous control, and 6.25 mL of
water. Specific primers and probes for RPE65 were obtained from
Applied Biosystems. The used sequences were designed using
Primer Express 1.0 software (supplied by Applied Biosystems) with
known gene-specific DNA and appropriate mRNA sequence of
RPE65 gene (Nicoletti et al, 1995) from Entrez Nucleotide’s search
tool on the World Wide Web (National Center of Biotechnology
Information (NCBI), Bethesda, MD). The following primers were
used: CGCCGCTCACAGCTCAT (forward) and ATCGAAGGA-
GACTGCCGGT (reverse). The sequence for specific fluorogenic
probe was ACAGGCAGGATCCCCCTCTGGC for RPE65. This
probe was labeled with FAM as reporter, whereas the probe for
endogenous control was VIC-associated. The sequence of PCR
product was tested for specificity using NCBI BLAST search
database (standard nucleotide–nucleotide BLAST) to exclude
possible cross-reactivity and amplification of another target gene.
The samples underwent following stages: stage 1, 501C for
2 min; stage 2, 951C for 10 min; and stage 3, 951C for 15 s followed
by 601C for 1 min. Stage 3 was repeated 45 times. Gene-specific
products were measured by means of an ABI Prism 7700
sequence detection system (Perkin-Elmer Applied Biosystems,
Foster City, CA) continuously for 45 cycles.
The relative quantity of specific RPE65 mRNA in the epidermal
keratinocytes was evaluated according to the manufacturer’s
protocol using comparative threshold cycle (CT) method (user
bulletin for ABI Prism 7700 sequence detection system), where the
relative quantity of RPE65 mRNA sample, normalized to a-actin as
endogenous control and relative to a calibrator, is given by 2DDCT.
DDCT results from mean DCT (mRNA from respective sample) minus
mean DCTcalibrator. The mean DCT value is the average DCT value of
five different donors. CT of b-actin subtracted from gene-specific CT
gives DCT. Calibrator is a basis sample and defined as 1  sample.
Before using the comparative CT method for quantitation, validation
experiments to demonstrate that efficiencies of target and reference
(endogenous control) are approximately equal, were performed
according to the instructions in the user bulletin for the ABI Prism
7700 detection system. Variables are described by means  SD.
Immunoblotting Immunoblotting was performed according to
methods described previously (Foedinger et al, 1998). Human
keratinocytes and ARPE-19 cells were used to obtain cell extracts.
Samples were washed with PBS and homogenized in 2% sodium
dodecyl sulfate (SDS, Bio-Rad, Hercules, CA) in 0.0625 M Tris-
buffered saline, pH 6.8, supplemented with 2 mM phenymethyl-
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sulfonyl fluoride (Sigma Chemical Co.), boiled, and centrifuged.
Extracted proteins were separated by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) using a 12% polyacrylamide gel and
transferred onto nitrocellulose membranes. Strips of nitrocellulose
were exposed to affinity-purified peptide specific rabbit anti-
RPE65 antibody diluted 1:100 for both extracts, overnight.
Additionally, nitrocellulose strips of keratinocyte and ARPE-19 cell
extracts were exposed to the antibody in the presence of an
excess of free synthetic peptide. For control, irrelevant rabbit IgG
(Sigma Chemical Co.) was used for immunoblotting. Strips were
washed and incubated with alkaline phosphatase-conjugated goat
anti-rabbit IgG (Promega, Madison WI). Bound antibody was
visualized by nitroblue tetrazolium/bromochloroindolyl phospha-
tase (Kirkegaard and Perry Laboratories, Gaithersburg, MD)
enzyme reaction.
Indirect immunoﬂuorescence Four-micrometer cryosections of
snap-frozen paraformaldehyde-lysine-periodate-fixed normal hu-
man skin were prepared, and indirect immunofluorescence was
performed. Sections were incubated with affinity purified anti-
RPE65 antibody, diluted 1:25, washed, and exposed to respective
second-step reagent. After being washed, sections were cover-
slipped, and examined using an Olympus BH 2-RFCA fluorescence
microscope (Olympus, Albertville, MO). For control, normal rabbit
IgG was used as first antibody.
Normal human keratinocytes were grown to near confluence in
eight-well chamber slides, fixed with paraformaldehyde-lysine-
periodate (McLean and Nakane, 1974) for 20 min, and permeabi-
lized with 0.1% Triton X-100 for 10 min. This fixative preserves
antigenic property of proteins as well as cell morphology and is
routinely used for ultrastructural studies in our laboratory (Hinter-
huber et al, 2002). For colocalization studies, we incubated the
keratinocytes with RBP (0.1 mg/100 mL) in culture medium for
1 min at 371C, washed, fixed, and exposed them to sheep anti-RBP
antibody diluted 1:50 and affinity-purified rabbit anti-RPE65 anti-
body diluted 1:25. Cells were washed in PBS and incubated with a
mixture of Alexa 488-conjugated donkey anti-sheep and TRITC-
conjugated donkey anti-rabbit IgG, diluted 1:100 for 1 h.
Cells were washed, embedded in Fluoprep (BioMe´rieux, Marcy
I’Etoile, France), and examined by confocal laser scan microscope
LSM 510 using multitracking mode (Zeiss, Oberkochen, Germany)
to separate the signal of each fluorescence and to prevent cross-
talk.
Complexation of RBP and [3H]retinoic acid and uptake
experiments To examine uptake of conjugated RBP–retinoid, a
complex of [3H]retinoic acid and RBP was performed according to
previous publications (Horwitz and Heller, 1973; Hodam et al, 1991;
Zanotti et al, 1994). [11,12-3H]Retinoic acid (1 mCi/mL) was
purchased from American Radiolabeled Chemicals (St. Louis,
MO) and used upon delivery under light protection. One-hundred
microliters of RBP (Biotrend) resolved in 100 mL of PBS and 50 mL
of [3H]retinoic acid (1 mCi/mL) were added to 850 mL of PBS and
incubated for 1 h at room temperature under gentle shaking and
light protection. Thereafter, this solution was sent over a Sephadex
LH20 (Amersham Bioscience, Piscataway, NJ) column to separate
unbound [3H]retinoic acid from the final preparation. The counts
per minute per microliter of the complex solution were measured
before (12007.3  364 cpm/mL) and after (5596  445 cpm/mL)
passing the Sephadex LH20 column. Proliferating human kerati-
nocytes grown in 35-mm petri dishes were used. After being
washed in PBS, cells were exposed to culture medium, containing
80 mL of the final [3H]retinoic acid–RBP complex preparation per
mL of culture medium, at 37, 4, and, at 371C in the presence of an
excess of unconjugated RBP (75 mg/mL culture medium), for
different time spans: 1, 3, 5, and 10 min. The culture medium
temperature was brought to 371C in a water bath before the
respective labeled RBP complex was added. 41C exposure was
performed on ice. After incubation, cells were washed, harvested
in PBS (1.5  105 cells per 300 mL of PBS), and counted for
radioactivity using Wallac 1410 liquid scintillation counter (Phar-
macia, Wallac Oy, Turku, Finland).
Statistics Statistical analysis was performed using the paired
Student’s t test and p values of less than 0.05 were considered
to indicate statistical significance. Variables are given as
means  SD.
Afﬁnity puriﬁcation of RPE65 from keratinocyte lysates Human
RBP (Biotrend) was covalently bound to a beaded polystyrene
polyoxyethylene graft copolymer resin with a coupling intensity of
0.22 mmol per g by piChem R & D. A quantity of 100 mg of that
RBP-coupled matrix gel was incubated in PBS for 20 min, followed
by washing. Cultured human keratinocytes of one petri dish were
lyzed in 1 mL of 1% Nonidet P-40 (NP-40) in Tris-HCl, pH 7.4, with
proteinase inhibitors and centrifuged at 3100 g. Proteins were
precipitated with ethanol:acetone 1:1 overnight at 201C, pelleted,
and air-dried. Then, the protein sample was dissolved in 1 mL of
PBS with 2 mM phenymethylsulfonyl fluoride and transferred to the
RBP-coupled matrix gel for 2 h under gentle shaking. Afterwards,
the matrix gel was washed with PBS, for 3  5 min, and
centrifuged. Thirty microliters of a 10% SDS sample buffer in
0.0625 M Tris-buffered saline, pH 6.8, supplemented with 2%
dithiothreitol (Sigma Chemical Co.) was added to the pellet, boiled,
and centrifuged. The supernatant was loaded onto a 12%
polyacrylamide gel separated by SDS-PAGE and transferred
electrophoretically onto nitrocellulose. Strips of nitrocellulose were
cut, exposed to affinity-purified anti-RPE65 antibody with or
without the presence of excess free peptide, and further processed
for immunoblotting as described above. Control immunoblots were
performed with irrelevant rabbit IgG. For additional control, only
RBP-matrix gel without NP-40 lysate was exposed to SDS sample
buffer, boiled, loaded, and processed for immunoblotting.
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